Home Top Movers Let's analyze why DBV Technologies (DBVT) shares rose in the premarket trading

Let’s analyze why DBV Technologies (DBVT) shares rose in the premarket trading

Here’s the Update…

 DBV Technologies (DBVT) stock rose 35.3% to $5.5in the premarket session after a biotech clinical-stage firm has stated that it has obtained written answers from the United States Food and Drug Administration (FDA) to the questions sent by the company to the Form A meeting in October 2020.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

After obtaining a Complete Response Letter (CRL) for its Biologics License Application (BLA) for Viaskin Peanut (DBV712), the organization received a Type A meeting order for a study, non-invasive, once regular epicutaneous patch for the treatment of peanut allergy in children aged between four and 11 years.

Read More

DBV claims that FDA feedback offers a well-defined regulatory direction. DBV suggested future resolutions in exchanges with the FDA to two major issues listed by the FDA in the CRL: the effect of patch adhesion and the need for patch improvements. In subsequent communications with the FDA, DBV will discuss specifics of a recent validation analysis for human factors and supplementary evidence on chemical engineering, production, and controls.

The FDA has agreed with DBV’s opinion that the improved Viaskin Peanut patch must not be treated as a new product agent if the original Viaskin Peanut patch’s occlusion chamber and the peanut protein dosage of 250 μg (round 1/1000 one peanut) are unchanged and usable.

FDA also called for an investigation evaluating the use of allergens (peanut protein) between the patches of allergic peanut children aged 4-11 to confirm the accuracy of effectiveness evidence between the current and updated patches. FDA has suggested that the updated Viaskin Peanut patch be conducted in the targeted patient group for a 6-month, well-monitored safety and adherence trial.

Company profile 

DBV Technologies is working on Viaskin, an experimental platform with potential application in immunotherapy. The Viaskin method is modeled after epicutaneous immunotherapy, which DBV has developed to deliver biologically active compounds to the immune system through intact skin. The company’s mission is to safeguard food allergic patients with these new non-invasive product candidates.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Summary 

Analysts hold a lot of potential for biotech stocks. However, those biotechs may fail in clinical trials, even if they do well in testing. Investments in biotech stocks can come with the significant risks of money running out, companies needing to pay for clinical studies, completing regulatory filings, and bringing new products to market.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Edesa Biotech Inc. (EDSA) stock surged during current market trading. Here’s to know why?

Edesa Biotech Inc. (NASDAQ: EDSA) stock gained by 4.22% in the current market trading. Edesa Biotech is a clinical-stage biopharmaceutical business dedicated on the...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Cleveland BioLabs Inc. (CBLI) stock surged during after-hour session. Here’s what’s happening?

Cleveland BioLabs Inc. (NASDAQ: CBLI) stock declined by 3.58% at the last close while the CBLI stock price gains by 17.53% during the after-hour...

Why Ares Commercial Real Estate Corp (ACRE) stock plummeted on Thursday?

Ares Commercial Real Estate Corporation (ACRE) shares slipped 4.35% in after-hours on Thursday, June 17, 2021, and close the trading at $15.60. Earlier, ACRE's...

Nano-X Imaging Ltd. (NNOX) stock gained in the current market trading. Here’s to know why?

Nano-X Imaging Ltd. (NASDAQ: NNOX) stock gained by 14.90% in the current market trading. Nanox which is an Israeli company started by serial entrepreneur...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam